NCT06468709 - A Trial on the Recurrence Free Survival Rate of Type I AIP With High-risk of Recurrence | Biotech Hunter

Enrollment

86

Participants

Timeline

Start Date

June 20, 2024

Primary Completion Date

March 31, 2027

Study Completion Date

July 31, 2027

Conditions

Type 1 AIP

Interventions

DRUG

Glucocorticoids

The study subjects were randomly divided into a GC monotherapy maintenance group and a GC combined with MMF maintenance group in a 1:1 ratio. The randomization sequence was generated online using a computer randomization scheme. Group A was the GC monotherapy maintenance group

DRUG

Glucocorticoids+MMF

The study subjects were randomly divided into a GC monotherapy maintenance group and a GC combined with MMF maintenance group in a 1:1 ratio. The randomization sequence was generated online using a computer randomization scheme. Group B was the GC+MMF maintenance group

Trial Locations (1)

200025

RECRUITING

Ruijin Hospital, Shanghai